NASDAQ: EVO
Evotec Se Stock Ownership - Who owns Evotec Se?

Insider buying vs selling

Have Evotec Se insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVO insiders and whales buy or sell their stock.

EVO Shareholders

What type of owners hold Evotec Se stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mubadala Investment Co Pjsc2.59%4,597,701$15.31MInstitution
Wellington Management Group LLP0.80%1,429,899$4.76MInstitution
Blackrock Inc0.73%1,300,009$4.33MInstitution
Dcf Advisers LLC0.67%1,198,993$3.99MInstitution
Morgan Stanley0.18%314,912$1.05MInstitution
Wcm Investment Management LLC0.17%300,277$999.92kInstitution
Pitcairn Co0.09%161,769$538.69kInstitution
Abc Arbitrage Sa0.07%132,057$439.75kInstitution
Citadel Advisors LLC0.05%96,045$319.83kInstitution
Envestnet Asset Management Inc0.04%75,711$252.12kInstitution

1 of 3

EVO vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVO5.56%0.00%
AMPH48.29%51.71%Net BuyingNet Selling
DVAX63.30%36.70%Net Selling
PCRX67.54%32.46%Net SellingNet Selling
ESPR45.18%17.13%Net SellingNet Selling

Evotec Se Stock Ownership FAQ

Who owns Evotec Se?

Evotec Se (NASDAQ: EVO) is owned by 5.56% institutional shareholders, 0.00% Evotec Se insiders, and 94.44% retail investors. Mubadala Investment Co Pjsc is the largest individual Evotec Se shareholder, owning 4.60M shares representing 2.59% of the company. Mubadala Investment Co Pjsc's Evotec Se shares are currently valued at $15.31M.

If you're new to stock investing, here's how to buy Evotec Se stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.